2005•Zhongguo yaofangRequires access

Cost-effectiveness Analysis of4Therapeutic Regimens for Cervicitis of Chlamydia Trachomatis

Zhong Li

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate the cost-effectiveness of 4 different therapeutic regimens for cervicitis of chlamydia trachomatis.METHODS:4therapeutic regimens including regimen A(azithromycin by oral administration),regimen B(azithromycin by intravenous injection),regimen C(minocycline by oral administration),regimen D(levofloxacin and deˉoxycycline by oral administration)were analyzed using cost-effectiveness analysis.RESULTS:The total costs of A,B,C,D4regimens were(645.20±109.56)yuan,(933.10±249.90)yuan,(413.14±38.04)yuan,and(489.00±83.60)yuan respectiveˉly;The effective rate were96.2%,98.6%,93.4%and94.1%respectively;The ratios of cost to effectiveness were6.71,9.46,4.42,and5.19respectively;As compared with regimen C,the incremental cost effectiveness ratios for regimen A,B and D were82.88,99.99,and108.37respectively.CONCLUSION:Regimen C is the preferable one.

About this research paper

What this paper is about

OBJECTIVE:To evaluate the cost-effectiveness of 4 different therapeutic regimens for cervicitis of chlamydia trachomatis.METHODS:4therapeutic regimens including regimen A(azithromycin by oral administration),regimen B(azithromycin by intravenous injection),regimen C(minocycline by oral administration),regimen D(levofloxacin and deˉoxycycline by oral administration)were analyzed using cost-effectiveness analysis.RESULTS:The total costs of A,B,C,D4regimens were(645.20±109.56)yuan,(933.10±249.90)yuan,(413.14±38.04)yuan,and(489.00±83.60)yuan respectiveˉly;The effective rate were96.2%,98.6%,93.4%and94.1%respectively;The ratios of cost to effectiveness were6.71,9.46,4.42,and5.19respectively;As compared with regimen C,the incremental cost effectiveness ratios for regimen A,B and D were82.88,99.99,and108.37respectively.CONCLUSION:Regimen C is the preferable one.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate the cost-effectiveness of 4 different therapeutic regimens for cervicitis of chlamydia trachomatis.METHODS:4therapeutic regimens including regimen A(azithromycin by oral administration),regimen B(azithromycin by intravenous injection),regimen C(minocycline by oral administration),regimen D(levofloxacin and deˉoxycycline by oral administration)were analyzed using cost-effectiveness analysis.RESULTS:The total costs of A,B,C,D4regimens were(645.20±109.56)yuan,(933.10±249.90)yuan,(413.14±38.04)yuan,and(489.00±83.60)yuan respectiveˉly;The effective rate were96.2%,98.6%,93.4%and94.1%respectively;The ratios of cost to effectiveness were6.71,9.46,4.42,and5.19respectively;As compared with regimen C,the incremental cost effectiveness ratios for regimen A,B and D were82.88,99.99,and108.37respectively.CONCLUSION:Regimen C is the preferable one.

Key concepts: Regimen, Azithromycin, Medicine, Chlamydia trachomatis, Cervicitis, Internal medicine, Cost effectiveness, Levofloxacin

Related papers

Back to paper searchBrowse research topicsOriginal source
Cost-effectiveness Analysis of4Therapeutic Regimens for Cervicitis of Chlamydia Trachomatis — Research Paper | ScholarLens